Welltower (WELL) delivered 22.1% same-store NOI growth and its 220th consecutive quarterly dividend, while Healthpeak (DOC) surged 40% year-to-date on a major earnings beat. <\/p>\n<\/li>\n
U.S. personal healthcare spending hit $3.7 trillion in May 2026, now absorbing roughly 25% of every services dollar and fueling senior housing demand. <\/p>\n<\/li>\n
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks \u2014 and Welltower didn’t make the cut. Grab the names FREE today<\/a>. <\/p>\n<\/li>\n<\/ul>\n America’s demographic clock keeps ticking, and the money is following the wrinkles. Personal consumption on healthcare hit $3,716.0 billion in May 2026, up from $3,512.1 billion a year earlier, a jump of $203.9 billion that outpaces overall services growth. Healthcare now absorbs roughly 24.5% of every services dollar. That is the demand curve behind senior housing and healthcare real estate, and it is why the three REITs below deserve a hard look this month. <\/p>\n All three trade on the NYSE, all three pay attractive dividends, and each is executing a specific playbook against the aging-Boomer tailwind. If you are building a dividend-heavy retirement sleeve, our monthly dividend research report pairs well with the picks below. <\/p>\n LTC Properties (NYSE: LTC) <\/p>\n LTC Properties (<\/strong>NYSE:LTC<\/strong><\/a>)<\/strong> is the small-cap transformation story in the group. Market cap sits at roughly $1.99B, shares changed hands at $41.24 on July 16, and the stock has climbed more than 19% year to date. The quarterly dividend of 57 cents per share pencils to a dividend yield near 5.83%, with the next ex-dividend date set for July 23, 2026. <\/p>\n Q1 2026 delivered adjusted EPS of 48 cents against a 40-cent consensus, a 20% beat, and revenue jumped 58.38% year over year to $95.41 million. Management reaffirmed full-year Core FFO\/share guidance of $2.75\u2013$2.79. <\/p>\n Act now:<\/strong> the analyst who called NVIDIA in 2010 just named his top 10 AI stocks \u2014 and Welltower didn’t make the cut. Grab the names FREE today<\/a>. <\/p>\n Bull case:<\/strong> The pivot to a Seniors Housing Operating Portfolio (SHOP) model is capturing the demographic upside directly. SHOP now represents 29% of gross investments and management is guiding to 45% by year-end 2026, with the core SHOP portfolio running at 89.4% occupancy and REVPOR of $7,998. CEO Clint Malin put it plainly: “We have strong conviction that our SHOP strategy is the right one to create a higher growth profile company with better risk-adjusted returns to drive shareholder value.” <\/p>\n Risk:<\/strong> Skilled nursing still accounts for 33% of gross investments, and the $179.9 million Prestige Healthcare mortgage carries prepayment risk beginning July 2026. Tenant concentration and execution risk on the SHOP conversion are the near-term watch items. <\/p>\n Story Continues <\/p>\n Healthpeak Properties (NYSE: DOC) <\/p>\n Healthpeak Properties (<\/strong>NYSE:DOC<\/strong><\/a>)<\/strong> is the mid-cap diversifier with a monthly paycheck. Market cap is $14.99 billion, shares traded around $22.18 on July 16, and the stock has surged 36.88% year to date. The monthly dividend of 10 cents per share supports a yield near 5.64%. <\/p>\n Q1 2026 GAAP EPS of 28 cents crushed the five-cent consensus, revenue of $752.95 million topped estimates by 8.63% and management raised full-year diluted EPS guidance to 46 cents to 50 cents from 34 cents to 38 cents. FFO as Adjusted guidance moved to $1.71\u2013$1.75. <\/p>\n Bull case:<\/strong> The Janus Living IPO printed $880 million in net proceeds at a $6.90 billion market cap, with Healthpeak retaining 81.6%, unlocking senior housing value while Janus lines up another $400 million in senior housing acquisitions. Senior housing same-store cash NOI grew 13.8% year over year in Q1, and the buyback program repurchased 5.9M shares at roughly $16.81 average, with about $306 million still authorized. <\/p>\n Risk:<\/strong> The lab segment is dragging. Same-store cash NOI fell 7.2% year over year in Q1 2026, and while management believes life science is near an inflection, occupancy is the swing variable through year-end. <\/p>\n Welltower (NYSE: WELL) <\/p>\n Welltower (<\/strong>NYSE:WELL<\/strong><\/a>)<\/strong> is the elephant. At $165.57 billion market cap, it is the largest healthcare REIT in the country, and the price action reflects the scale advantage. Shares traded around $239.46 on July 16, up 28.09% year to date and 51.99% over the past 12 months. <\/p>\n Q1 2026 normalized FFO landed at $1.47 per share on revenue of $3.35 billion, up 40.3% year over year. Guidance was raised across the board: net income per share to $3.24\u2013$3.38 and normalized FFO\/share to $6.21\u2013$6.35, with blended same-store NOI growth guided to 12.25%\u201316.00%. The quarterly dividend of $0.74 was Welltower’s 220th consecutive quarterly dividend, following a 10.4% increase the prior period. <\/p>\n Bull case:<\/strong> The Seniors Housing Operating segment produced 22.1% same-store NOI growth, occupancy climbed 370 bps year over year to 89.0%, and margin expanded to 30.9% from 27.7%. With $10.5B in year-to-date investment activity closed or under contract, 92.3% private-pay revenue mix, and net debt\/EBITDA at a lean 3.03x, Welltower is compounding scale advantages faster than smaller peers can match. Analysts back the setup, with a $241 average price target and 12 Buy ratings and five Strong Buy ratings. <\/p>\n Risk:<\/strong> Valuation. Forward P\/E of 79x and EV\/EBITDA of 68x leave no margin for execution slippage. Interest expense climbed from $144.9M to $192.7M year over year, and integration risk on the Barchester and HC-One UK acquisitions adds an FX overlay. <\/p>\n What to Watch Into Q3 <\/p>\n Housing starts weakened to 1.18M units in May 2026, a 15.4% month-over-month drop that will eventually tighten senior housing supply, a bullish setup for existing landlords. Keep an eye on the LTC ex-dividend date on July 23, the DOC ex-dividend date on July 20, and Q2 earnings reports later this summer for confirmation that the SHOP tailwind is still accelerating. The demographic thesis is durable; the entry points still matter. <\/p>\n Act now:<\/strong> the analyst who called NVIDIA in 2010 just named his top 10 AI stocks \u2014 and Welltower didn’t make the cut. Grab the names FREE today<\/a>. <\/p>\n<\/a> 24\/7 Wall St. <\/p>\n